The Emory University School of Medicine is the graduate medical school of Emory University and a component of Emory’s Robert W. Woodruff Health Sciences Center. Before it was established as the Emory School of Medicine in 1915, the school first began as the Atlanta Medical College.

During the past decade, Emory University School of Medicine conducted 114 clinical trials. In the 10-year time frame, 114 clinical trials started and 89 clinical trials were completed, i.e. on average, 78.1% percent of trials that started reached the finish line to date. In the past 5 years, 48 clinical trials started and 47 clinical trials were completed. i.e. 97.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Emory University School of Medicine" #1 sponsor was "Emory University" with 26 trials, followed by "Pfizer" with 9 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 8 trials sponsored, "Centers for Disease Control and Prevention" with 7 trials sponsored and "Bristol-Myers Squibb" with 7 trials sponsored. Other sponsors include 215 different institutions and companies that sponsored additional 160 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Emory University School of Medicine" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 17 trials as a collaborator, "Emory University" with 13 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 11 trials as a collaborator, "National Cancer Institute (NCI)" with 9 trials as a collaborator and "National Institutes of Health (NIH)" with 6 trials as a collaborator. Other collaborators include 238 different institutions and companies that were collaborators in the rest 174 trials.

According to Clinical.Site data, the most researched conditions in "Emory University School of Medicine" are "HIV Infections" (15 trials), "Fabry Disease" (9 trials), "Sickle Cell Disease" (8 trials), "Stroke" (8 trials) and "Heart Failure" (7 trials). Many other conditions were trialed in "Emory University School of Medicine" in a lesser frequency.

Most popular intervention types in "Emory University School of Medicine" are "Drug" (170 trials), "Biological" (38 trials), "Other" (27 trials), "Device" (21 trials) and "Procedure" (13 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (55 trials), "placebo" (6 trials), "Fluconazole" (5 trials), "MT-1186" (4 trials) and "Hydroxyurea" (3 trials). Other intervention names were less common.

The vast majority of trials in "Emory University School of Medicine" are 260 trials for "All" genders, 12 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Emory University School of Medicine". undefined are not yet recruiting, 34 are recruiting, 28 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 176 completed trials in Emory University School of Medicine, 4 suspended trials, and 19 terminated clinical trials to date.

Out of the total trials that were conducted in Emory University School of Medicine, 23 "Phase 1" clinical trials were conducted, 89 "Phase 2" clinical trials and 80 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 21 trials, and there were also 43 trials that are defined as “Not Applicable".